Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Xellar Biosystems | 2026 | Series A | Undisclosed | Newton |
| Healing Paper | 2025 | Series C | $29.7M | Seocho |
| Saige Research | 2023 | Series B | $11.6M | Seoul |
| N1 Life | 2023 | Seed | $10.0M | Milpitas |
| Sanegene Bio | 2025 | Series B | $110.0M | Woburn |
| Zhijian Power | 2026 | Series Unknown | Undisclosed | Hangzhou |
| Manifold AI | 2026 | Seed | $28.9M | Chaoyang |
| VITURE | 2026 | Series Unknown | $100.0M | San Francisco |
| X Square | 2026 | Series A | Undisclosed | Shenzhen |
| Zhiran Medical | 2026 | Series A | $43.4M | Beijing |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Xellar Biosystems | Series A | Undisclosed | Newton, United States |
| 2 | Healing Paper | Series C | $29.7M | Seocho, South Korea |
| 3 | Saige Research | Series B | $11.6M | Seoul, South Korea |
| 4 | N1 Life | Seed | $10.0M | Milpitas, United States |
| 5 | Sanegene Bio | Series B | $110.0M | Woburn, United States |
| 6 | Zhijian Power | Series Unknown | Undisclosed | Hangzhou, China |
| 7 | Manifold AI | Seed | $28.9M | Chaoyang, China |
| 8 | VITURE | Series Unknown | $100.0M | San Francisco, United States |
| 9 | X Square | Series A | Undisclosed | Shenzhen, China |
| 10 | Zhiran Medical | Series A | $43.4M | Beijing, China |
Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.
Healing Paper uses ICT to improve medical service access, reduce costs, and balance information between experts and non-experts.
Saige Research specializes in artificial intelligence solutions for industrial inspection and quality control.
A biotech comany advancing tissue-selective drug delivery platform technologies to revolutionize drug development.
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.
Zhijian Power is a high-tech enterprise specializing in the research and development of intelligent driving technology.
Manifold AI is an artificial intelligence company that provides development of embodied intelligent world models.
VITURE is a 2C technology company dedicated to developing AR technology, creating trendy XR glasses.
X Square is a company aiming to create a universal brain-cerebellum system for robots, encompassing capabilities from perception to action.
Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders.
GluBio Therapeutics engages in molecular glue-targeted protein degradation drug discovery.
Huixin Bio is a developer of exosome purification products and early cancer detection technology.
Neolix is a technology company that designs, manufactures, and operates low-cost autonomous delivery vehicles.
Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.
An AI & Robotics Company based in Shenzhen,China.
Guoke Ion is an innovative enterprise focusing on the integration of advanced medical technology and financial services.
Nowwa Coffee is a coffee chain brand that provides freshly ground coffee and tea, peripherals, roasting, and other products.
Ensurge Medical is a medical equipment developer, specializing in R&D, production, and sales of intelligent medical products.
Alioth focuses on the development and application of technical products for pharmaceutical process technology.
Wepure develops, manufactures, and distributes nano-microspheres made of silica gel and resin.
TuringQ is committed to the research of quantum information and manufactures optical quantum chips and optical quantum computers.
Atom Reshape's 3D printer goods are primarily aimed for the C-end consumer market.
Memsilicon specializes in research and development solutions for RRAM storage and AI computing technologies.
Tailan New Energy is a solid-state battery company.
Sinsegye operates as a product-driven enterprise company.
Legend Capital has invested in 203 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Legend Capital's top investment sectors include Artificial Intelligence (AI), Medical, Health Care, Biotechnology, Biopharma. The firm invests across 38 different industry categories.
Among tracked funding rounds, Angitia Biopharmaceuticals received $130.0M in a Series D round. Legend Capital's total known invested capital is $4.9B.
Legend Capital's average investment size is $37.7M across its portfolio of 203 companies.
Recent Legend Capital portfolio additions include Xellar Biosystems, Healing Paper, Saige Research, N1 Life, Sanegene Bio. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors